GO
Loading...

Enter multiple symbols separated by commas

FDA

More

  • June 12- The U.S. Food and Drug Administration said it approved a brain implant from St. Jude Medical Inc that helps reduce symptoms of Parkinson's disease and essential tremor, a neurological disorder that causes rhythmic shaking. The device can be used when medication alone may not provide adequate relief from symptoms such as walking difficulties, balance...

  • Listeria outbreak freezes Blue Bell Thursday, 11 Jun 2015 | 8:00 AM ET
    Listeria outbreak freezes Blue Bell

    Blue Bell identified the source of the listeria outbreak at its Oklahoma facility as one unsanitary room.

  • ZURICH, June 11- The U.S. Food and Drug Administration is testing samples of a Nestle instant noodle brand that was recalled from stores across India last week, a spokeswoman for the Swiss food group said on Thursday. A spokeswoman for the Swiss-based company said the United States' FDA was now also looking into the issue. "We have been made aware that the FDA has taken...

  • ZURICH, June 11- The U.S. Food and Drug Administration is testing samples of a Nestle instant noodle brand that was recalled from stores across India last week, a spokeswoman for the Swiss food group said on Thursday. A spokeswoman for the Swiss-based company said the United States' FDA was now also looking into the issue. "We have been made aware that the FDA has taken...

  • LOS ANGELES, June 10- A U.S. government inspection of food service facilities at Los Angeles International Airport found dirty employee bathrooms and food preparation issues, according to documents made public on Wednesday by a union representing airline food workers. The report from a Food and Drug Administration inspection conducted in January was...

  • Insulet gets FDA warning letter over some insulin pumps Wednesday, 10 Jun 2015 | 6:05 PM ET

    June 10- Insulet Corp said on Wednesday it received a warning letter from the U.S. Food and Drug Administration over some of the company's insulin pumps. The company said the letter, which it received on Monday, followed an inspection by the FDA of its facility in Billerica, Massachusetts in March. The letter relates to the release of certain lots of the company's...

  • Why a FDA nod isn't enough for Regeneron shares Wednesday, 10 Jun 2015 | 12:49 PM ET
    A technician at Regeneron Pharmaceuticals headquarters in Tarrytown, N.Y.

    Regeneron's shares sank 4 percent despite a positive Food and Drug Administration recommendation on a cholesterol drug. What gives?

  • 10 drugs to hit fed budget by $50B over decade Tuesday, 9 Jun 2015 | 1:42 PM ET
    Health Care

    Ten so-called breakthrough drugs for cancers and chronic conditions will cost taxpayers big bucks.

  • FDA targets 'bad' cholesterol drug Tuesday, 9 Jun 2015 | 6:31 AM ET
    FDA targets 'bad' cholesterol drug

    CNBC's Meg Tirrell reports the FDA meets today and tomorrow to discuss and vote on recommendation for approval of new cholesterol drugs, Praluent and Repatha.

  • June 8- Biotechnology company Neurocrine Biosciences Inc said it had suspended two planned clinical trials of its experimental drug to treat a potentially life-threatening genetic disorder called congenital adrenal hyperplasia. The U.S. Food and Drug Administration has informed Neurocrine that the drug's development program would be placed on...

  • WASHINGTON, June 5- An experimental drug made by Sanofi SA and Regeneron Pharmaceuticals Inc effectively lowers bad LDL cholesterol and is generally well tolerated, according to a preliminary review by the U.S. Food and Drug Administration. The review was published on Friday before a meeting on Tuesday of a panel of outside advisers to the FDA who will discuss...

  • For Paion AG, that's an opportunity. Paion says that will give its proprietary drug an edge over two established anesthetics, which have long since come off patent and are available as low-cost generics. Paion is pushing for the drug, now being tested on patients undergoing colonoscopies, to be approved by the U.S. Food and Drug Administration for use without an...

  • WASHINGTON, June 5- A drug made by Sanofi SA and Regeneron Pharmaceuticals Inc effectively lowers bad LDL cholesterol and is generally well tolerated, according to a preliminary review by the U.S. Food and Drug Administration. The review was published on Friday on the FDA's website before a meeting Tuesday of a panel of outside advisers who will discuss the drug...

  • FDA panel approves 'female Viagra' drug Friday, 5 Jun 2015 | 7:55 AM ET
    FDA panel approves 'female Viagra' drug

    CNBC's Meg Tirrell reports on the woman's libido drug.

  • 'Female Viagra' drug gets FDA panel support Friday, 5 Jun 2015 | 4:38 AM ET
    Prescription drugs

    A drug to treat low female sexual desire should be approved with strict measures to ensure patients are aware of its risks, an FDA panel concluded.

  • The FDA has twice rejected the drug, flibanserin, made by privately held Sprout Pharmaceuticals. Palatin estimates the combined global market for the two drugs at between $1.5 billion and $2 billion. The panel's recommendation follows months of lobbying by Sprout, aided by a number of women's advocacy groups which accused the FDA of gender bias since the...

  • WASHINGTON, June 4- A drug to treat low female sexual desire should be approved with strict measures in place to ensure patients are fully aware of its risks, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday. The FDA, which has twice rejected the drug, flibanserin, is not obliged to follow the advice of its advisory panels but typically...

  • FDA panel backs approval of women's libido drug Thursday, 4 Jun 2015 | 4:19 PM ET

    WASHINGTON, June 4- A drug to treat low female sexual desire should be approved with strict procedures in place to ensure patients are fully aware of its risks, including fainting and low blood pressure, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday. The FDA, which has twice rejected the drug, flibanserin, is not obliged to follow...

  • 'Female Viagra' up for consideration again Thursday, 4 Jun 2015 | 7:00 AM ET
    'Female Viagra' up for consideration again

    The FDA is again considering approval for Fibanserin, "the female Viagra."

  • These are the 9 worst chain restaurant meals Wednesday, 3 Jun 2015 | 12:17 PM ET
    Red Lobster in Times Square, New York.

    Get prepared to hit the treadmill after eating these calorie-laden dishes.